Entry
Name
Tebapivat (USAN/INN)
Formula
C18H16N8OS
Exact mass
392.1168
Mol weight
392.44
Structure
Mol file KCF file DB search
Efficacy
Anti-anemic, Pyruvate kinase-R activator
Comment
Treatment of hemolytic anemias associated with sickle cell disease; and other hematopoietic disorders, like anemia associated with myelodysplastic syndrome
Target
Pathway
Brite
Target-based classification of drugs [BR:br08310 ]
Enzymes
Transferases (EC2)
Phosphotransferase
PKLR
D13032 Tebapivat (USAN/INN)
BRITE hierarchy
Other DBs
LinkDB
All DBs
KCF data
Show ATOM 28
1 C8y C 20.0200 -19.6700
2 C8y C 20.0200 -21.0700
3 C8y C 18.6900 -21.4900
4 C8y C 17.8500 -20.3700
5 N4y N 18.6900 -19.2500
6 N5x N 21.3500 -19.2500
7 C8y C 22.1900 -20.3700
8 S2x S 21.3500 -21.4900
9 C8x C 18.1300 -22.7500
10 N5x N 16.7300 -22.9600
11 N4y N 15.8900 -21.7700
12 C8y C 16.4500 -20.5100
13 O5x O 15.6100 -19.3900
14 C1b C 14.4900 -21.9100
15 C1a C 18.2700 -17.9200
16 C1b C 23.5900 -20.3700
17 C8y C 24.2900 -19.1800
18 N5x N 23.7300 -17.9200
19 N4x N 24.7800 -16.9400
20 C8x C 25.9700 -17.6400
21 C8x C 25.6900 -19.0400
22 C8y C 13.9271 -23.1918
23 N5x N 12.5409 -23.3445
24 C8y C 11.9779 -24.6263
25 C8x C 12.8065 -25.7548
26 C8x C 14.1926 -25.6021
27 C8x C 14.7556 -24.3203
28 N1a N 10.5771 -24.7806
BOND 32
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 1 5 1
6 1 6 1
7 6 7 2
8 7 8 1
9 2 8 1
10 3 9 1
11 9 10 2
12 10 11 1
13 11 12 1
14 4 12 1
15 12 13 2
16 11 14 1
17 5 15 1
18 7 16 1
19 16 17 1
20 17 18 2
21 18 19 1
22 19 20 1
23 20 21 2
24 17 21 1
25 14 22 1
26 22 23 2
27 23 24 1
28 24 25 2
29 25 26 1
30 26 27 2
31 22 27 1
32 24 28 1